Clinical Trial Update: Sickle Cell Disease: A Retrospective Chart Review

View source ↗

Summary

This document reports a retrospective chart review in sickle cell disease sponsored by Novartis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Sickle Cell Anemia | Status: COMPLETED